Featured on CNBC The Exchange: AbCellera CEO on raising $105 million in series B funding

post

“CNBC’s Meg Tirrell interviews Carl Hansen, AbCellera CEO, about how the company is working on coronavirus drugs.”

See full broadcast video on CNBC.

PARTNERSHIP

Together we can make game-changing discoveries.

Let's talk